Many with Advanced Dementia Receiving Drugs of Uncertain Benefit

April 10, 2017

(Medscape) – The use of medications that have questionable benefits for patients in the terminal stages of dementia is widespread, and continues even in the final days before death, a new Canadian study has found. The study showed that 45% of nursing home residents with dementia who received at least one medication of questionable benefit within the last year of life continued to get these drugs in the last week before death. This is despite recommendations to reduce aggressive and burdensome interventions in these patients.

Recommended Reading